Alligator Bioscience
0.38 SEK
-6.07 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-6.07 %
+13.04 %
-67.59 %
-63.71 %
-93.50 %
-94.52 %
-98.39 %
-99.60 %
-99.92 %
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
252.37M SEK
Turnover
825.58K SEK
Revenue
57.77M
EBIT %
-396.64 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
6/5
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Alligator Bioscience comments on Henlius receiving regulatory approval in China to initiate Phase 2/3 trials of HLX22 in HER2-positive breast cancer
BioStock: Alligator Bioscience: ”We are in a very good place”
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools